Patent details

EP2252631 Title: BCR-COMPLEX-SPECIFIC ANTIBODIES AND METHODS OF USING SAME

Basic Information

Publication number:
EP2252631
PCT Application Number:
PCT/US/2009/038171
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097630107
PCT Publication Number:
WO/2009/151717
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BCR-COMPLEX-SPECIFIC ANTIBODIES AND METHODS OF USING SAME
French Title of Invention:
ANTICORPS SPÉCIFIQUES DU COMPLEXE BCR ET PROCÉDÉS POUR LES UTILISER
German Title of Invention:
BCR-KOMPLEX-SPEZIFISCHE ANTIKÖRPER UND VERFAHREN ZU IHRER VERWENDUNG
SPC Number:

Dates

Filing date:
25/03/2009
Grant date:
13/04/2016
EP Publication Date:
13/04/2016
PCT Publication Date:
17/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/11/2010
EP B1 Publication Date:
13/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/03/2017
Expiration date:
25/03/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/09/2016
 
 

Name:
MacroGenics Inc.
Address:
9704 Medical Center Drive, Rockville, MD 20850, United States (US)

Inventor

1

Name:
JOHNSON Leslie S.
Address:
United States (US)

2

Name:
HUANG Ling
Address:
United States (US)

Priority

Priority Number:
41659 P
Priority Date:
02/04/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages